These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33912438)

  • 1. Systemic Chemotherapy Including Ramucirumab in Combination With Pressurized Intra-Peritoneal Aerosol Chemotherapy Is a Safe Treatment Option for Peritoneal Metastasis of Gastric Cancer.
    Feldbrügge L; Gronau F; Brandl A; Auer TA; Oeff A; Thuss-Patience P; Pratschke J; Rau B
    Front Oncol; 2020; 10():610572. PubMed ID: 33912438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Cancer Patients with Peritoneal Metastasis (PM): Results of a Single-Center Experience and Register Study.
    Gockel I; Jansen-Winkeln B; Haase L; Rhode P; Mehdorn M; Niebisch S; Moulla Y; Lyros O; Lordick F; Schierle K; Wittekind C; Thieme R
    J Gastric Cancer; 2018 Dec; 18(4):379-391. PubMed ID: 30607301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in combination with FOLFOX chemotherapy as a first-line treatment for gastric cancer patients with peritoneal metastases: single-arm phase II study.
    Luksta M; Bausys A; Bickaite K; Rackauskas R; Paskonis M; Luksaite-Lukste R; Ranceva A; Stulpinas R; Brasiuniene B; Baltruskeviciene E; Lachej N; Sabaliauskaite R; Bausys R; Tulyte S; Strupas K
    BMC Cancer; 2023 Oct; 23(1):1032. PubMed ID: 37875869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis.
    Di Giorgio A; Schena CA; El Halabieh MA; Abatini C; Vita E; Strippoli A; Inzani F; Rodolfino E; Romanò B; Pacelli F; Rotolo S
    Surg Oncol; 2020 Sep; 34():270-275. PubMed ID: 32891341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized control trial comparing quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) and intravenous chemotherapy.
    Somashekhar SP; Ashwin KR; Rauthan CA; Rohit KC
    Pleura Peritoneum; 2018 Sep; 3(3):20180110. PubMed ID: 30911661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is long-term survival in patients with peritoneal metastasis from gastric, pancreatic, or colorectal cancer? A study of patients treated with systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC).
    Kryh-Jensen CG; Fristrup CW; Ainsworth AP; Detlefsen S; Mortensen MB; Pfeiffer P; Tarpgaard LS; Graversen M
    Pleura Peritoneum; 2023 Dec; 8(4):147-155. PubMed ID: 38144215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis.
    Nadiradze G; Giger-Pabst U; Zieren J; Strumberg D; Solass W; Reymond MA
    J Gastrointest Surg; 2016 Feb; 20(2):367-73. PubMed ID: 26511950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study.
    Ellebæk SB; Graversen M; Detlefsen S; Lundell L; Fristrup CW; Pfeiffer P; Mortensen MB
    Clin Exp Metastasis; 2020 Apr; 37(2):325-332. PubMed ID: 32002724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressurized IntraPeritoneal Aerosol Chemotherapy vs. intravenous chemotherapy for unresectable peritoneal metastases secondary to platinum resistant ovarian cancer - study protocol for a randomized control trial.
    Somashekhar SP; Ashwin KR; Rauthan A; Rohit KC
    Pleura Peritoneum; 2019 Mar; 4(1):20180111. PubMed ID: 31198851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIPAC EstoK 01: Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C/D) in gastric peritoneal metastasis: a randomized and multicenter phase II study.
    Eveno C; Jouvin I; Pocard M
    Pleura Peritoneum; 2018 Jun; 3(2):20180116. PubMed ID: 30911659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with gastric cancer and peritoneal metastasis.
    Javanbakht M; Mashayekhi A; Branagan-Harris M; Horvath P; Königsrainer A; Reymond MA; Yaghoubi M
    Eur J Surg Oncol; 2022 Jan; 48(1):188-196. PubMed ID: 34479745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional chemotherapy in gastric cancer with peritoneal metastasis combining intravenous XELOX with intraperitoneal chemotherapy with low-dose cisplatin and Doxorubicin administered as a pressurized aerosol: an open-label, Phase-2 study (PIPAC-GA2).
    Khomyakov V; Ryabov A; Ivanov A; Bolotina L; Utkina A; Volchenko N; Kaprin A
    Pleura Peritoneum; 2016 Sep; 1(3):159-166. PubMed ID: 30911619
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.
    Robella M; Vaira M; De Simone M
    World J Surg Oncol; 2016 Apr; 14():128. PubMed ID: 27125996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and Safety of Laparoscopic D2 Gastrectomy in Combination with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Gastric Cancer at High Risk of Recurrence-The PIPAC-OPC4 Study.
    Graversen M; Rouvelas I; Ainsworth AP; Bjarnesen AP; Detlefsen S; Ellebaek SB; Fristrup CW; Liljefors MG; Lundell L; Nilsson M; Pfeiffer P; Tarpgaard LS; Tsekrekos A; Mortensen MB
    Ann Surg Oncol; 2023 Jul; 30(7):4433-4441. PubMed ID: 36867174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)-directed treatment of peritoneal metastasis in end-stage colo-rectal cancer patients.
    Ellebæk SB; Graversen M; Detlefsen S; Lundell L; Fristrup CW; Pfeiffer P; Mortensen MB
    Pleura Peritoneum; 2020 Jun; 5(2):20200109. PubMed ID: 32566727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).
    Odendahl K; Solass W; Demtröder C; Giger-Pabst U; Zieren J; Tempfer C; Reymond MA
    Eur J Surg Oncol; 2015 Oct; 41(10):1379-85. PubMed ID: 26138283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Pressurized IntraPeritoneal Aerosol Chemotherapy in the management of gastric cancer: A systematic review.
    Garg PK; Jara M; Alberto M; Rau B
    Pleura Peritoneum; 2019 Mar; 4(1):20180127. PubMed ID: 31198852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer.
    Alyami M; Bonnot PE; Mercier F; Laplace N; Villeneuve L; Passot G; Bakrin N; Kepenekian V; Glehen O
    Eur J Surg Oncol; 2021 Jan; 47(1):123-127. PubMed ID: 32561204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review on quality of life (QoL) of patients with peritoneal metastasis (PM) who underwent pressurized intraperitoneal aerosol chemotherapy (PIPAC).
    Li Z; Wong LCK; Sultana R; Lim HJ; Tan JW; Tan QX; Wong JSM; Chia CS; Ong CJ
    Pleura Peritoneum; 2022 Jun; 7(2):39-49. PubMed ID: 35812010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne.
    Casella F; Bencivenga M; Rosati R; Fumagalli UR; Marrelli D; Pacelli F; Macrì A; Donini A; Torroni L; Pavarana M; De Manzoni G
    Pleura Peritoneum; 2022 Sep; 7(3):135-141. PubMed ID: 36159218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.